Anyone here who hasn't run their eye over Qbiotics, should..
- Unlisted (unknown = cheap)
- Veterinary drug EBC46 almost commercialised - this will underpin commercialisation of the human drug
- Human EBC46 having unreal preliminary results. At least 1 melanoma totally destructed in toxicology testing (doses are low, very low)
- Rick Holliday-Smith at the helm, skin in the game, getting remunerated with 80c options (current price is ~40c)
- Rick touting Qbiotics to be the next COH (cool 10 bil market cap...)
- THEN... this wound healing drug.. where do you start there, no competition in market, signs of it being regenerative not just aiding in closing of wounds.. hmmm ... military, cosmetics? where does it stop
I'd seriously love to hear any adverse comments about it because i can;t see much at the moment.
